In honor of Rare Disease Day on February 28, 2025, we will publish a series of posts throughout the month on As Prescribed ...

The analysis of numerous clinical trials saw an uptick in Indigenous American and Asian participants in decentralised trials.

By and large, sponsors and other stakeholders now recognise the intrinsic benefits of DCTs in improving access to clinical trials and enhancing flexibility for patients. This recognition is ...

The U.S. Food and Drug Administration (FDA), and the Office of Human Research protections (OHRP) released draft guidance titled, “Considerations ...

The merger will enable us to even better serve all clinical trial stakeholders as we work with our new colleagues to redefine the site and patient experience. By putting these two industry ...

Each active clinical trial scoped to transition would need its own strategic roadmap, where stakeholders — sponsors, CROs, and sites — were on the same page at every step, including the ...